$IKT Inhibikase Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inhibikase Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Inhibikase Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Inhibikase Therapeutics, Inc. for free.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: IKT
Company Address: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA 30339
Inhibikase Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 2.92 | 22,677 | 66,217 | 22,677 | |
| Jun 29 2021 | IKT | Inhibikase Therape ... | Freeman Roy Lester | Director | Option Exercise | A | 2.92 | 22,677 | 66,217 | 22,677 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | BERMAN DENNIS N | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | O'Farrell Elizabeth G. | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | Freeman Roy Lester | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | Werner Milton H. | President and CEO | Option Exercise | A | 10.00 | 100,000 | 1,000,000 | 100,000 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | BERMAN DENNIS N | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | FRATTAROLI JOSEPH | Chief Financial Off ... | Option Exercise | A | 10.00 | 100,000 | 1,000,000 | 100,000 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | O'Farrell Elizabeth G. | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | FRATTAROLI JOSEPH | Chief Financial Off ... | Buy | C | 10.00 | 44,143 | 441,430 | 44,143 | 0 to 44.1 K |
| Dec 29 2020 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | Freeman Roy Lester | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | Werner Milton H. | President and CEO | Option Exercise | A | 10.00 | 100,000 | 1,000,000 | 100,000 | |
| Dec 29 2020 | IKT | Inhibikase Therape ... | FRATTAROLI JOSEPH | Chief Financial Off ... | Option Exercise | A | 10.00 | 100,000 | 1,000,000 | 100,000 |
View all Inhibikase Therapeutics, Inc. insider transactions.